Clearside Biomedical names VP business development | Personnel Moves, Nov. 8, 2016

Clearside Biomedical (NSDQ:CLSD) today named Rick McElheny as its VP of business development. The Alpharetta, Ga.-based company is developing a microinjector loaded with CLS-TA (triamcinolone acetonide) to treat macular edema. The device is designed to inject the compound in the a 30-µm gap between the choroid and the sclera, called the suprachoroidal space. A pivotal Phase III trial of the treatment is under way. Get the full story at our sister site, Drug Delivery Business News. The post Clearside Biomedical names VP business development | Personnel Moves, Nov. 8, 2016 appeared first on MassDevice.
Source: Mass Device - Category: Medical Equipment Authors: Tags: Drug-Device Combinations Optical/Ophthalmic Clearside Biomedical Johnson & Johnson Personnel Moves Source Type: news